vanilmandelic acid has been researched along with Cerebral Primitive Neuroectodermal Tumor in 2 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The differential diagnosis was primitive neuroectodermal tumor." | 1.33 | The thyroid: an extremely rare primary site of neuroblastoma. ( Chaubey, A; Gupta, P; Kumar, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirayama, M | 1 |
| Azuma, E | 1 |
| Araki, M | 1 |
| Komada, Y | 1 |
| Nakagawa, A | 1 |
| Kumar, M | 1 |
| Gupta, P | 1 |
| Chaubey, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Research of Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Children With Stage 4/M Neuroblastoma: A Prospective, Single-arm, Phase II, Multi-center Trial[NCT05303727] | Phase 2 | 64 participants (Anticipated) | Interventional | 2022-08-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for vanilmandelic acid and Cerebral Primitive Neuroectodermal Tumor
| Article | Year |
|---|---|
Evidence of graft-versus-tumor effect in refractory metastatic neuroblastoma.
Topics: Antigens, CD; Bone Marrow Cells; Child; Cyclosporine; Female; Graft vs Tumor Effect; Homovanillic Ac | 2006 |
The thyroid: an extremely rare primary site of neuroblastoma.
Topics: Biomarkers, Tumor; Child; Diagnosis, Differential; Humans; Lymph Nodes; Lymphatic Metastasis; Male; | 2006 |